- Home
- CELU vs CLIR Comparison
CELU vs CLIR Comparison
Compare CELU & CLIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- CLIR
- Stock Information
- Founded
- CELU 2016
- CLIR 2008
- Country
- CELU United States
- CLIR United States
- Employees
- CELU N/A
- CLIR N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- CLIR Industrial Machinery/Components
- Sector
- CELU Health Care
- CLIR Industrials
- Exchange
- CELU Nasdaq
- CLIR Nasdaq
- Market Cap
- CELU 50.4M
- CLIR 59.3M
- IPO Year
- CELU N/A
- CLIR 2012
- Fundamental
- Price
- CELU $2.30
- CLIR $1.51
- Analyst Decision
- CELU
- CLIR Strong Buy
- Analyst Count
- CELU 0
- CLIR 1
- Target Price
- CELU N/A
- CLIR $6.00
- AVG Volume (30 Days)
- CELU 89.6K
- CLIR 193.6K
- Earning Date
- CELU 12-06-2024
- CLIR 11-14-2024
- Dividend Yield
- CELU N/A
- CLIR N/A
- EPS Growth
- CELU N/A
- CLIR N/A
- EPS
- CELU N/A
- CLIR N/A
- Revenue
- CELU $48,200,000.00
- CLIR $4,280,000.00
- Revenue This Year
- CELU N/A
- CLIR $69.16
- Revenue Next Year
- CELU $233.89
- CLIR $440.76
- P/E Ratio
- CELU N/A
- CLIR N/A
- Revenue Growth
- CELU 225.94
- CLIR 263.02
- 52 Week Low
- CELU $1.30
- CLIR $0.62
- 52 Week High
- CELU $7.97
- CLIR $1.72
- Technical
- Relative Strength Index (RSI)
- CELU 52.94
- CLIR 65.50
- Support Level
- CELU $2.04
- CLIR $1.07
- Resistance Level
- CELU $2.39
- CLIR $1.45
- Average True Range (ATR)
- CELU 0.17
- CLIR 0.17
- MACD
- CELU 0.02
- CLIR 0.01
- Stochastic Oscillator
- CELU 70.76
- CLIR 68.66
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from bio-banking segment.
About CLIR ClearSign Technologies Corporation (DE)
ClearSign Technologies Corp is engaged in providing solutions to some of the pressing productivity, energy efficiency, and pollution problems affecting the energy, oil, and gas production, boiler, and processing industries. It believes that its patented ClearSign Core technology can enhance the performance of combustion systems in a broad range of markets, including the energy (upstream oil production and downstream refining), institutional, commercial, and industrial boiler, chemical, and petrochemical industries. The company offers products that include process burners, boiler burners, flares, and ClearSign Eye.